Market Overview:
Cutaneous mastocytosis is a rare skin disorder that results in the accumulation of mast cells in the skin. These cells are responsible for releasing histamine and other chemicals that can cause inflammation, itching, and redness. The global cutaneous mastocytosis market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The growth of this market is mainly driven by the increasing prevalence of cutaneous mastocytosis, rising awareness about this disease, and growing demand for effective treatment options. The global cutaneous mastocytosis market can be segmented on the basis of type, application, and region. On the basis of type, the market can be divided into indolent (smoldering) form and aggressive form. On the basis of application, it can be classified into hospitals, ambulatory surgical centers (ASCs), and others (clinics/private practice settings).
Product Definition:
Cutaneous mastocytosis is a skin disorder that results in the accumulation of mast cells in the skin. Mast cells are immune system cells that play a role in allergic reactions. Cutaneous mastocytosis can cause redness, itching, and swelling of the skin.
Antihistamines:
Antihistamines are used to treat itching. They work by decreasing the histamine response. The most common types of antihistamines are diphenhydramine, brompheniramine, chlorpheniramine and triprolidine.
Corticosteroids:
Corticosteroids are the group of drugs that act as anti-inflammatory agents. Corticosteroid medications are used to reduce inflammation by decreasing the production of cytokines (substances that trigger inflammation). Some people with cutaneous mastocytosis may also require other medications, such as immunosuppressants or biologic response modifiers.
Application Insights:
The others segment held the largest share of the global cutaneous mastocytosis market in 2017. This can be attributed to a high incidence rate of other applications, such as cosmetic surgeries and chronic pain management, across various regions. In addition, an increase in awareness about CMM is also expected to contribute towards growth during the forecast period.
Hospitals are anticipated to remain the dominant segment over the forecast period due to factors such as availability of advanced treatment facilities and highly skilled staff members who are capable of handling complex cases related to CMM. Furthermore, hospitals offer complete confidentiality and privacy for patients suffering from rare diseases or conditions that may intimidate patients living at home without medical supervision or support systems at home.
Regional Analysis:
North America dominated the global market in 2017. The presence of key players, favorable reimbursement scenario, and increasing prevalence of cutaneous mastocytosis are some factors responsible for its dominance. In addition, the availability of highly advanced healthcare infrastructure is expected to drive regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising disposable income and improving healthcare facilities in emerging countries such as China and India. Furthermore, an increase in awareness about various treatment options along with a rise in incidence rate is also expected to boost market development during this period.
Growth Factors:
- Increasing incidence of Cutaneous Mastocytosis due to changing lifestyle and environmental factors.
- Growing awareness about Cutaneous Mastocytosis and its early diagnosis among people.
- Rising demand for better treatment options for Cutaneous Mastocytosis patients.
- Technological advancements in the field of dermatology that are helping in the diagnosis and treatment of Cutaneous Mastocytosis patients effectively .
Scope Of The Report
Report Attributes
Report Details
Report Title
Cutaneous Mastocytosis Market Research Report
By Type
Antihistamines, Corticosteroids, Proton Pump Inhibitors, Immunomodulators, Mast Cell Stabilizers
By Application
Hospitals, Ambulatory Surgical Centers, Others
By Companies
AB Science, Novartis, BioCentury, Rarediseases
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
215
Number of Tables & Figures
151
Customization Available
Yes, the report can be customized as per your need.
Global Cutaneous Mastocytosis Market Report Segments:
The global Cutaneous Mastocytosis market is segmented on the basis of:
Types
Antihistamines, Corticosteroids, Proton Pump Inhibitors, Immunomodulators, Mast Cell Stabilizers
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Ambulatory Surgical Centers, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- AB Science
- Novartis
- BioCentury
- Rarediseases
Highlights of The Cutaneous Mastocytosis Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Antihistamines
- Corticosteroids
- Proton Pump Inhibitors
- Immunomodulators
- Mast Cell Stabilizers
- By Application:
- Hospitals
- Ambulatory Surgical Centers
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cutaneous Mastocytosis Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Cutaneous mastocytosis is a rare skin disorder that causes the overproduction of mast cells. These cells are responsible for the body's immune response, and when they're overproduced, they can cause skin lesions and other problems. Cutaneous mastocytosis is most commonly diagnosed in adults age 30 to 50, but it can also occur in children or young adults.
Some of the major companies in the cutaneous mastocytosis market are AB Science, Novartis, BioCentury, Rarediseases.
The cutaneous mastocytosis market is expected to register a CAGR of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cutaneous Mastocytosis Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Cutaneous Mastocytosis Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Cutaneous Mastocytosis Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Cutaneous Mastocytosis Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Cutaneous Mastocytosis Market Size & Forecast, 2018-2028
4.5.1 Cutaneous Mastocytosis Market Size and Y-o-Y Growth
4.5.2 Cutaneous Mastocytosis Market Absolute $ Opportunity
Chapter 5 Global Cutaneous Mastocytosis Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Cutaneous Mastocytosis Market Size Forecast by Type
5.2.1 Antihistamines
5.2.2 Corticosteroids
5.2.3 Proton Pump Inhibitors
5.2.4 Immunomodulators
5.2.5 Mast Cell Stabilizers
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Cutaneous Mastocytosis Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Cutaneous Mastocytosis Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Ambulatory Surgical Centers
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cutaneous Mastocytosis Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cutaneous Mastocytosis Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Cutaneous Mastocytosis Analysis and Forecast
9.1 Introduction
9.2 North America Cutaneous Mastocytosis Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Cutaneous Mastocytosis Market Size Forecast by Type
9.6.1 Antihistamines
9.6.2 Corticosteroids
9.6.3 Proton Pump Inhibitors
9.6.4 Immunomodulators
9.6.5 Mast Cell Stabilizers
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Cutaneous Mastocytosis Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Ambulatory Surgical Centers
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Cutaneous Mastocytosis Analysis and Forecast
10.1 Introduction
10.2 Europe Cutaneous Mastocytosis Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Cutaneous Mastocytosis Market Size Forecast by Type
10.6.1 Antihistamines
10.6.2 Corticosteroids
10.6.3 Proton Pump Inhibitors
10.6.4 Immunomodulators
10.6.5 Mast Cell Stabilizers
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Cutaneous Mastocytosis Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Ambulatory Surgical Centers
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Cutaneous Mastocytosis Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Cutaneous Mastocytosis Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Cutaneous Mastocytosis Market Size Forecast by Type
11.6.1 Antihistamines
11.6.2 Corticosteroids
11.6.3 Proton Pump Inhibitors
11.6.4 Immunomodulators
11.6.5 Mast Cell Stabilizers
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Cutaneous Mastocytosis Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Ambulatory Surgical Centers
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Cutaneous Mastocytosis Analysis and Forecast
12.1 Introduction
12.2 Latin America Cutaneous Mastocytosis Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Cutaneous Mastocytosis Market Size Forecast by Type
12.6.1 Antihistamines
12.6.2 Corticosteroids
12.6.3 Proton Pump Inhibitors
12.6.4 Immunomodulators
12.6.5 Mast Cell Stabilizers
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Cutaneous Mastocytosis Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Ambulatory Surgical Centers
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Cutaneous Mastocytosis Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Cutaneous Mastocytosis Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Cutaneous Mastocytosis Market Size Forecast by Type
13.6.1 Antihistamines
13.6.2 Corticosteroids
13.6.3 Proton Pump Inhibitors
13.6.4 Immunomodulators
13.6.5 Mast Cell Stabilizers
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Cutaneous Mastocytosis Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Ambulatory Surgical Centers
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cutaneous Mastocytosis Market: Competitive Dashboard
14.2 Global Cutaneous Mastocytosis Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 AB Science
14.3.2 Novartis
14.3.3 BioCentury
14.3.4 Rarediseases
